Year |
Citation |
Score |
2024 |
Katsumura KR, Liu P, Kim JA, Mehta C, Bresnick EH. Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program. Proceedings of the National Academy of Sciences of the United States of America. 121: e2317147121. PMID 38422019 DOI: 10.1073/pnas.2317147121 |
0.617 |
|
2022 |
Fraga de Andrade I, Johnson KD, Mehta C, Dewey C, Basu U, Bresnick EH. RNA-Regulatory Exosome Complex Suppresses an Apoptotic Program to Confer Erythroid Progenitor Cell Survival In Vivo. Blood Advances. PMID 36161469 DOI: 10.1182/bloodadvances.2022008481 |
0.582 |
|
2021 |
Mehta C, Fraga de Andrade I, Matson DR, Dewey CN, Bresnick EH. RNA-regulatory exosome complex confers cellular survival to promote erythropoiesis. Nucleic Acids Research. PMID 34059908 DOI: 10.1093/nar/gkab367 |
0.623 |
|
2020 |
Zwifelhofer NM, Cai X, Liao R, Mao B, Conn DJ, Mehta C, Keles S, Xia Y, Bresnick EH. GATA factor-regulated solute carrier ensemble reveals a nucleoside transporter-dependent differentiation mechanism. Plos Genetics. 16: e1009286. PMID 33370779 DOI: 10.1371/journal.pgen.1009286 |
0.542 |
|
2020 |
Fraga de Andrade I, Mehta C, Bresnick EH. Post-transcriptional control of cellular differentiation by the RNA exosome complex. Nucleic Acids Research. PMID 33119769 DOI: 10.1093/nar/gkaa883 |
0.523 |
|
2020 |
You X, Chang YI, Kong G, Ranheim EA, Zhou Y, Johnson KD, Mehta C, Bresnick EH, Zhang J. Gata2 -77 enhancer regulates adult hematopoietic stem cell survival. Leukemia. PMID 32594099 DOI: 10.1038/S41375-020-0942-6 |
0.575 |
|
2020 |
Cavalcante de Andrade Silva M, Katsumura KR, Mehta C, Velloso EDRP, Bresnick EH, Godley LA. Breaking the spatial constraint between neighboring zinc fingers: a new germline mutation in GATA2 deficiency syndrome. Leukemia. PMID 32286542 DOI: 10.1038/S41375-020-0820-2 |
0.526 |
|
2019 |
Soukup AA, Zheng Y, Mehta C, Wu J, Liu P, Cao M, Hofmann I, Zhou Y, Zhang J, Johnson KD, Choi K, Keles S, Bresnick EH. Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer. The Journal of Clinical Investigation. PMID 30620726 DOI: 10.1172/Jci122694 |
0.64 |
|
2019 |
Katsumura KR, Liu P, Mehta C, Hewitt KJ, Soukup A, Fraga de Andrade IJ, Ranheim EA, Johnson KD, Bresnick EH. Loss-of-Function and Gain-of-Function Consequences of GATA2 Disease Mutations Blood. 134: 2519-2519. DOI: 10.1182/Blood-2019-129447 |
0.63 |
|
2019 |
Mehta C, Fraga de Andrade IJ, Tanimura N, Wilson GM, Ranheim EA, Coon JJ, Bresnick EH. Elucidating an Erythroblast Survival Mechanism: Differential Contributions of Exosome Complex Catalytic Subunits Blood. 134: 155-155. DOI: 10.1182/Blood-2019-126917 |
0.608 |
|
2018 |
Katsumura KR, Mehta C, Hewitt KJ, Soukup AA, Fraga de Andrade I, Ranheim EA, Johnson KD, Bresnick EH. Human leukemia mutations corrupt but do not abrogate GATA-2 function. Proceedings of the National Academy of Sciences of the United States of America. PMID 30301799 DOI: 10.1073/Pnas.1813015115 |
0.645 |
|
2018 |
Bresnick EH, Hewitt KJ, Mehta C, Keles S, Paulson RF, Johnson KD. Mechanisms of erythrocyte development and regeneration: implications for regenerative medicine and beyond. Development (Cambridge, England). 145. PMID 29321181 DOI: 10.1242/Dev.151423 |
0.582 |
|
2018 |
McIver SC, Hewitt KJ, Gao X, Mehta C, Zhang J, Bresnick EH. Dissecting Regulatory Mechanisms Using Mouse Fetal Liver-Derived Erythroid Cells. Methods in Molecular Biology (Clifton, N.J.). 1698: 67-89. PMID 29076084 DOI: 10.1007/978-1-4939-7428-3_4 |
0.611 |
|
2018 |
Soukup A, Mehta C, Liu P, Cao M, Hofmann I, Zhou Y, Zhang J, Choi K, Johnson KD, Bresnick EH. Single-Nucleotide Human Disease Mutation Inactivates a Blood-Regenerative Enhancer Blood. 132: 2564-2564. DOI: 10.1182/Blood-2018-99-113008 |
0.565 |
|
2018 |
Soukup A, Johnson K, Mehta C, Zhou Y, Zhang J, Bresnick E. GATA-2 Dependent Hematologic Disease Mechanism Experimental Hematology. 64: S45. DOI: 10.1016/J.Exphem.2018.06.054 |
0.521 |
|
2017 |
Mehta C, Johnson KD, Gao X, Ong I, Katsumura KR, McIver SC, Ranheim EA, Bresnick EH. Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program. Blood. 130: 7. PMID 31940664 DOI: 10.1182/Blood.V130.Suppl_1.7.7 |
0.539 |
|
2017 |
Mehta C, Johnson KD, Gao X, Ong IM, Katsumura KR, McIver SC, Ranheim EA, Bresnick EH. Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program. Cell Reports. 20: 2966-2979. PMID 28930689 DOI: 10.1016/J.Celrep.2017.08.090 |
0.656 |
|
2017 |
Bresnick E, Hewitt K, Mehta C, Johnson K, Matson D, Katsumura K, Gao X, McIver S, Devadas P, Hebert A, Coon J, Kim J, Ong I, Ranheim E, Dewey C, et al. Enhancer mechanisms governing developmental and regenerative hematopoietic programs Experimental Hematology. 53: S28. DOI: 10.1016/J.Exphem.2017.06.018 |
0.549 |
|
Show low-probability matches. |